僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Datopotamab （CDP7657） is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan （HY-141598）, TROP2-directed antibody-drug conjugate （ADC）. Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan （HY-13631E） and Datopotamab